Eli Lilly and Company
ELI LILLY AND COMPANY
Exchange / Market
Eli Lilly and Company is one of the world’s leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- neurology (33.5%): primarily drugs used in treating depression and schizophrenia;
- endocrinology (30.1%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (14.5%);
- cardiovascular diseases (11.7%);
- veterinary medicine (9%);
- other (1.2%).
Net sales are distributed geographically as follows: the United States (54.5%), Europe (18.9%), Japan (9.9%) and other (16.7%).